世界のダルファンプリジン市場予測 2020年-2025年

【英語タイトル】Global Dalfampridine Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20OC1044)・商品コード:LPI20OC1044
・発行会社(調査会社):LP Information
・発行日:2020年10月2日(※2024年版があります。お問い合わせください)
・ページ数:137
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:Pharma & Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「ダルファンプリジンの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、10mg、その他など、用途別には、病院、クリニック、その他などに区分してまとめた調査レポートです。ダルファンプリジンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・ダルファンプリジンの世界市場概要(サマリー)
・ダルファンプリジンの企業別販売量・売上
・ダルファンプリジンの企業別市場シェア
・ダルファンプリジンの世界市場規模 2015年-2020年:種類別(10mg、その他)
・ダルファンプリジンの世界市場規模 2015年-2020年:用途別(病院、クリニック、その他)
・ダルファンプリジンの米州市場規模(アメリカ、カナダ、メキシコなど)
・ダルファンプリジンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ダルファンプリジンの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ダルファンプリジンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ダルファンプリジン市場の成長要因・課題・動向
・ダルファンプリジンの世界市場予測 2021年-2025年
・ダルファンプリジンの米州市場予測(アメリカ、カナダ、メキシコなど)
・ダルファンプリジンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ダルファンプリジンの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ダルファンプリジンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ダルファンプリジンの世界市場予測:種類別(10mg、その他)
・ダルファンプリジンの世界市場予測:用途別(病院、クリニック、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Dalfampridine market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dalfampridine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Dalfampridine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Dalfampridine, covering the supply chain analysis, impact assessment to the Dalfampridine market size growth rate in several scenarios, and the measures to be undertaken by Dalfampridine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
10 mg
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Acorda Therapeutics
Elan Pharma
Sun Pharmaceutical
Aurobindo Pharma
Biogen

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Dalfampridine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Dalfampridine market by identifying its various subsegments.
Focuses on the key global Dalfampridine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Dalfampridine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Dalfampridine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dalfampridine Consumption 2015-2025
2.1.2 Dalfampridine Consumption CAGR by Region
2.2 Dalfampridine Segment by Type
2.2.1 10 mg
2.2.2 Others
2.3 Dalfampridine Consumption by Type
2.3.1 Global Dalfampridine Consumption Market Share by Type (2015-2020)
2.3.2 Global Dalfampridine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Dalfampridine Sale Price by Type (2015-2020)
2.4 Dalfampridine Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Dalfampridine Consumption by Application
2.5.1 Global Dalfampridine Consumption Market Share by Type (2015-2020)
2.5.2 Global Dalfampridine Value and Market Share by Type (2015-2020)
2.5.3 Global Dalfampridine Sale Price by Type (2015-2020)

3 Global Dalfampridine by Company
3.1 Global Dalfampridine Sales Market Share by Company
3.1.1 Global Dalfampridine Sales by Company (2018-2020)
3.1.2 Global Dalfampridine Sales Market Share by Company (2018-2020)
3.2 Global Dalfampridine Revenue Market Share by Company
3.2.1 Global Dalfampridine Revenue by Company (2018-2020)
3.2.2 Global Dalfampridine Revenue Market Share by Company (2018-2020)
3.3 Global Dalfampridine Sale Price by Company
3.4 Global Dalfampridine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Dalfampridine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Dalfampridine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Dalfampridine by Regions
4.1 Dalfampridine by Regions
4.2 Americas Dalfampridine Consumption Growth
4.3 APAC Dalfampridine Consumption Growth
4.4 Europe Dalfampridine Consumption Growth
4.5 Middle East & Africa Dalfampridine Consumption Growth

5 Americas
5.1 Americas Dalfampridine Consumption by Countries
5.1.1 Americas Dalfampridine Consumption by Countries (2015-2020)
5.1.2 Americas Dalfampridine Value by Countries (2015-2020)
5.2 Americas Dalfampridine Consumption by Type
5.3 Americas Dalfampridine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Dalfampridine Consumption by Regions
6.1.1 APAC Dalfampridine Consumption by Regions (2015-2020)
6.1.2 APAC Dalfampridine Value by Regions (2015-2020)
6.2 APAC Dalfampridine Consumption by Type
6.3 APAC Dalfampridine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Dalfampridine by Countries
7.1.1 Europe Dalfampridine Consumption by Countries (2015-2020)
7.1.2 Europe Dalfampridine Value by Countries (2015-2020)
7.2 Europe Dalfampridine Consumption by Type
7.3 Europe Dalfampridine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Dalfampridine by Countries
8.1.1 Middle East & Africa Dalfampridine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Dalfampridine Value by Countries (2015-2020)
8.2 Middle East & Africa Dalfampridine Consumption by Type
8.3 Middle East & Africa Dalfampridine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dalfampridine Distributors
10.3 Dalfampridine Customer

11 Global Dalfampridine Market Forecast
11.1 Global Dalfampridine Consumption Forecast (2021-2025)
11.2 Global Dalfampridine Forecast by Regions
11.2.1 Global Dalfampridine Forecast by Regions (2021-2025)
11.2.2 Global Dalfampridine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Dalfampridine Forecast by Type
11.8 Global Dalfampridine Forecast by Application

12 Key Players Analysis
12.1 Acorda Therapeutics
12.1.1 Company Information
12.1.2 Dalfampridine Product Offered
12.1.3 Acorda Therapeutics Dalfampridine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Acorda Therapeutics Latest Developments
12.2 Elan Pharma
12.2.1 Company Information
12.2.2 Dalfampridine Product Offered
12.2.3 Elan Pharma Dalfampridine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Elan Pharma Latest Developments
12.3 Sun Pharmaceutical
12.3.1 Company Information
12.3.2 Dalfampridine Product Offered
12.3.3 Sun Pharmaceutical Dalfampridine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sun Pharmaceutical Latest Developments
12.4 Aurobindo Pharma
12.4.1 Company Information
12.4.2 Dalfampridine Product Offered
12.4.3 Aurobindo Pharma Dalfampridine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Aurobindo Pharma Latest Developments
12.5 Biogen
12.5.1 Company Information
12.5.2 Dalfampridine Product Offered
12.5.3 Biogen Dalfampridine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Biogen Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Dalfampridine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 10 mg
Table 5. Major Players of Others
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Dalfampridine Consumption Market Share by Type (2015-2020)
Table 8. Global Dalfampridine Revenue by Type (2015-2020) ($ million)
Table 9. Global Dalfampridine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Dalfampridine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Dalfampridine Consumption Market Share by Application (2015-2020)
Table 13. Global Dalfampridine Value by Application (2015-2020)
Table 14. Global Dalfampridine Value Market Share by Application (2015-2020)
Table 15. Global Dalfampridine Sale Price by Application (2015-2020)
Table 16. Global Dalfampridine Sales by Company (2017-2019) (K Units)
Table 17. Global Dalfampridine Sales Market Share by Company (2017-2019)
Table 18. Global Dalfampridine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Dalfampridine Revenue Market Share by Company (2017-2019)
Table 20. Global Dalfampridine Sale Price by Company (2017-2019)
Table 21. Global Dalfampridine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Dalfampridine Products Offered
Table 23. Dalfampridine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Dalfampridine Consumption by Regions 2015-2020 (K Units)
Table 25. Global Dalfampridine Consumption Market Share by Regions 2015-2020
Table 26. Global Dalfampridine Value by Regions 2015-2020 ($ Millions)
Table 27. Global Dalfampridine Value Market Share by Regions 2015-2020
Table 28. Americas Dalfampridine Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Dalfampridine Consumption Market Share by Countries (2015-2020)
Table 30. Americas Dalfampridine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Dalfampridine Value Market Share by Countries (2015-2020)
Table 32. Americas Dalfampridine Consumption by Type (2015-2020) (K Units)
Table 33. Americas Dalfampridine Consumption Market Share by Type (2015-2020)
Table 34. Americas Dalfampridine Consumption by Application (2015-2020) (K Units)
Table 35. Americas Dalfampridine Consumption Market Share by Application (2015-2020)
Table 36. APAC Dalfampridine Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Dalfampridine Consumption Market Share by Countries (2015-2020)
Table 38. APAC Dalfampridine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Dalfampridine Value Market Share by Regions (2015-2020)
Table 40. APAC Dalfampridine Consumption by Type (2015-2020) (K Units)
Table 41. APAC Dalfampridine Consumption Market Share by Type (2015-2020)
Table 42. APAC Dalfampridine Consumption by Application (2015-2020) (K Units)
Table 43. APAC Dalfampridine Consumption Market Share by Application (2015-2020)
Table 44. Europe Dalfampridine Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Dalfampridine Consumption Market Share by Countries (2015-2020)
Table 46. Europe Dalfampridine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Dalfampridine Value Market Share by Countries (2015-2020)
Table 48. Europe Dalfampridine Consumption by Type (2015-2020) (K Units)
Table 49. Europe Dalfampridine Consumption Market Share by Type (2015-2020)
Table 50. Europe Dalfampridine Consumption by Application (2015-2020) (K Units)
Table 51. Europe Dalfampridine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Dalfampridine Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Dalfampridine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Dalfampridine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Dalfampridine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Dalfampridine Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Dalfampridine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Dalfampridine Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Dalfampridine Consumption Market Share by Application (2015-2020)
Table 60. Dalfampridine Distributors List
Table 61. Dalfampridine Customer List
Table 62. Global Dalfampridine Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Dalfampridine Consumption Market Forecast by Regions
Table 64. Global Dalfampridine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Dalfampridine Value Market Share Forecast by Regions
Table 66. Global Dalfampridine Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Dalfampridine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Dalfampridine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Dalfampridine Value Market Share Forecast by Type (2021-2025)
Table 70. Global Dalfampridine Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Dalfampridine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Dalfampridine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Dalfampridine Value Market Share Forecast by Application (2021-2025)
Table 74. Acorda Therapeutics Product Offered
Table 75. Acorda Therapeutics Dalfampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 76. Acorda Therapeutics Main Business
Table 77. Acorda Therapeutics Latest Developments
Table 78. Acorda Therapeutics Basic Information, Company Total Revenue (in $ million), Dalfampridine Manufacturing Base, Sales Area and Its Competitors
Table 79. Elan Pharma Product Offered
Table 80. Elan Pharma Dalfampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 81. Elan Pharma Main Business
Table 82. Elan Pharma Latest Developments
Table 83. Elan Pharma Basic Information, Company Total Revenue (in $ million), Dalfampridine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sun Pharmaceutical Product Offered
Table 85. Sun Pharmaceutical Dalfampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 86. Sun Pharmaceutical Main Business
Table 87. Sun Pharmaceutical Latest Developments
Table 88. Sun Pharmaceutical Basic Information, Company Total Revenue (in $ million), Dalfampridine Manufacturing Base, Sales Area and Its Competitors
Table 89. Aurobindo Pharma Product Offered
Table 90. Aurobindo Pharma Dalfampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 91. Aurobindo Pharma Main Business
Table 92. Aurobindo Pharma Latest Developments
Table 93. Aurobindo Pharma Basic Information, Company Total Revenue (in $ million), Dalfampridine Manufacturing Base, Sales Area and Its Competitors
Table 94. Biogen Product Offered
Table 95. Biogen Dalfampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 96. Biogen Main Business
Table 97. Biogen Latest Developments
Table 98. Biogen Basic Information, Company Total Revenue (in $ million), Dalfampridine Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Dalfampridine
Figure 2. Dalfampridine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Dalfampridine Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Dalfampridine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 10 mg
Figure 7. Product Picture of Others
Figure 8. Global Dalfampridine Consumption Market Share by Type (2015-2020)
Figure 9. Global Dalfampridine Value Market Share by Type (2015-2020)
Figure 10. Dalfampridine Consumed in Hospitals
Figure 11. Global Dalfampridine Market: Hospitals (2015-2020) (K Units)
Figure 12. Global Dalfampridine Market: Hospitals (2015-2020) ($ Millions)
Figure 13. Dalfampridine Consumed in Clinics
Figure 14. Global Dalfampridine Market: Clinics (2015-2020) (K Units)
Figure 15. Global Dalfampridine Market: Clinics (2015-2020) ($ Millions)
Figure 16. Dalfampridine Consumed in Others
Figure 17. Global Dalfampridine Market: Others (2015-2020) (K Units)
Figure 18. Global Dalfampridine Market: Others (2015-2020) ($ Millions)
Figure 19. Global Dalfampridine Consumption Market Share by Application (2015-2020)
Figure 20. Global Dalfampridine Value Market Share by Application (2015-2020)
Figure 21. Global Dalfampridine Sales Market Share by Company in 2017
Figure 22. Global Dalfampridine Sales Market Share by Company in 2019
Figure 23. Global Dalfampridine Revenue Market Share by Company in 2017
Figure 24. Global Dalfampridine Revenue Market Share by Company in 2019
Figure 25. Global Dalfampridine Sale Price by Company in 2019
Figure 26. Global Dalfampridine Consumption Market Share by Regions 2015-2020
Figure 27. Global Dalfampridine Value Market Share by Regions 2015-2020
Figure 28. Americas Dalfampridine Consumption 2015-2020 (K Units)
Figure 29. Americas Dalfampridine Value 2015-2020 ($ Millions)
Figure 30. APAC Dalfampridine Consumption 2015-2020 (K Units)
Figure 31. APAC Dalfampridine Value 2015-2020 ($ Millions)
Figure 32. Europe Dalfampridine Consumption 2015-2020 (K Units)
Figure 33. Europe Dalfampridine Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Dalfampridine Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Dalfampridine Value 2015-2020 ($ Millions)
Figure 36. Americas Dalfampridine Consumption Market Share by Countries in 2019
Figure 37. Americas Dalfampridine Value Market Share by Countries in 2019
Figure 38. Americas Dalfampridine Consumption Market Share by Type in 2019
Figure 39. Americas Dalfampridine Consumption Market Share by Application in 2019
Figure 40. United States Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 41. United States Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Dalfampridine Consumption Market Share by Countries in 2019
Figure 47. APAC Dalfampridine Value Market Share by Regions in 2019
Figure 48. APAC Dalfampridine Consumption Market Share by Type in 2019
Figure 49. APAC Dalfampridine Consumption Market Share by Application in 2019
Figure 50. China Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 51. China Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 58. India Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 59. India Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Dalfampridine Consumption Market Share by Countries in 2019
Figure 63. Europe Dalfampridine Value Market Share by Countries in 2019
Figure 64. Europe Dalfampridine Consumption Market Share by Type in 2019
Figure 65. Europe Dalfampridine Consumption Market Share by Application in 2019
Figure 66. Germany Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 68. France Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 69. France Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 70. UK Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 71. UK Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Dalfampridine Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Dalfampridine Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Dalfampridine Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Dalfampridine Consumption Market Share by Application in 2019
Figure 80. Egypt Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Dalfampridine Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Dalfampridine Value Growth 2015-2020 ($ Millions)
Figure 90. Global Dalfampridine Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Dalfampridine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Dalfampridine Consumption 2021-2025 (K Units)
Figure 93. Americas Dalfampridine Value 2021-2025 ($ Millions)
Figure 94. APAC Dalfampridine Consumption 2021-2025 (K Units)
Figure 95. APAC Dalfampridine Value 2021-2025 ($ Millions)
Figure 96. Europe Dalfampridine Consumption 2021-2025 (K Units)
Figure 97. Europe Dalfampridine Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Dalfampridine Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Dalfampridine Value 2021-2025 ($ Millions)
Figure 100. United States Dalfampridine Consumption 2021-2025 (K Units)
Figure 101. United States Dalfampridine Value 2021-2025 ($ Millions)
Figure 102. Canada Dalfampridine Consumption 2021-2025 (K Units)
Figure 103. Canada Dalfampridine Value 2021-2025 ($ Millions)
Figure 104. Mexico Dalfampridine Consumption 2021-2025 (K Units)
Figure 105. Mexico Dalfampridine Value 2021-2025 ($ Millions)
Figure 106. Brazil Dalfampridine Consumption 2021-2025 (K Units)
Figure 107. Brazil Dalfampridine Value 2021-2025 ($ Millions)
Figure 108. China Dalfampridine Consumption 2021-2025 (K Units)
Figure 109. China Dalfampridine Value 2021-2025 ($ Millions)
Figure 110. Japan Dalfampridine Consumption 2021-2025 (K Units)
Figure 111. Japan Dalfampridine Value 2021-2025 ($ Millions)
Figure 112. Korea Dalfampridine Consumption 2021-2025 (K Units)
Figure 113. Korea Dalfampridine Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Dalfampridine Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Dalfampridine Value 2021-2025 ($ Millions)
Figure 116. India Dalfampridine Consumption 2021-2025 (K Units)
Figure 117. India Dalfampridine Value 2021-2025 ($ Millions)
Figure 118. Australia Dalfampridine Consumption 2021-2025 (K Units)
Figure 119. Australia Dalfampridine Value 2021-2025 ($ Millions)
Figure 120. Germany Dalfampridine Consumption 2021-2025 (K Units)
Figure 121. Germany Dalfampridine Value 2021-2025 ($ Millions)
Figure 122. France Dalfampridine Consumption 2021-2025 (K Units)
Figure 123. France Dalfampridine Value 2021-2025 ($ Millions)
Figure 124. UK Dalfampridine Consumption 2021-2025 (K Units)
Figure 125. UK Dalfampridine Value 2021-2025 ($ Millions)
Figure 126. Italy Dalfampridine Consumption 2021-2025 (K Units)
Figure 127. Italy Dalfampridine Value 2021-2025 ($ Millions)
Figure 128. Russia Dalfampridine Consumption 2021-2025 (K Units)
Figure 129. Russia Dalfampridine Value 2021-2025 ($ Millions)
Figure 130. Spain Dalfampridine Consumption 2021-2025 (K Units)
Figure 131. Spain Dalfampridine Value 2021-2025 ($ Millions)
Figure 132. Egypt Dalfampridine Consumption 2021-2025 (K Units)
Figure 133. Egypt Dalfampridine Value 2021-2025 ($ Millions)
Figure 134. South Africa Dalfampridine Consumption 2021-2025 (K Units)
Figure 135. South Africa Dalfampridine Value 2021-2025 ($ Millions)
Figure 136. Israel Dalfampridine Consumption 2021-2025 (K Units)
Figure 137. Israel Dalfampridine Value 2021-2025 ($ Millions)
Figure 138. Turkey Dalfampridine Consumption 2021-2025 (K Units)
Figure 139. Turkey Dalfampridine Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Dalfampridine Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Dalfampridine Value 2021-2025 ($ Millions)
Figure 142. Acorda Therapeutics Dalfampridine Market Share (2018-2020)
Figure 143. Elan Pharma Dalfampridine Market Share (2018-2020)
Figure 144. Sun Pharmaceutical Dalfampridine Market Share (2018-2020)
Figure 145. Aurobindo Pharma Dalfampridine Market Share (2018-2020)
Figure 146. Biogen Dalfampridine Market Share (2018-2020)


★調査レポート[世界のダルファンプリジン市場予測 2020年-2025年] (コード:LPI20OC1044)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のダルファンプリジン市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆